Adaptive Biotechnologies - Seattle, 12.5 million shares, priced $15-$17, managed by Goldman Sachs/JP Morgan. Proposed Nasdaq symbol ADPT.
News
- Initial public offerings scheduled to debut next week
- Wyoming Business Council recommends $9.3M for Cheyenne plant
(AP) — The Wyoming Business Council board has recommended the state approve a $9.35 million loan for the construction of a biomedical ...
- Stocks wobble a day after hitting record high
Health care and real estate companies led the decliners. Biotechnology company AbbVie fell 2.2%. Utilities swayed between small gains and losses.
- 6 things wealthy people do to protect their money when they get married
Elizabeth Holmes, the disgraced founder of the biotech startup Theranos, married her fiancé Billy Evans in secret, according to a report earlier this ...
- Researchers find new mutation in the leptin gene
San Antonio, Texas (June 19, 2019) - The global obesity epidemic is so far-reaching it now has an overarching name: globesity. Texas Biomed Staff ...